The 2026 annual Bloom Burton & Co. Healthcare Investor Conference—Canada's premier international forum for healthcare companies and investors—was ...
In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024. While the year saw an overall ...
The national health care and life science merger and acquisition landscape remained weak in the first quarter of 2024, according to the latest data from international audit and advisory firm KPMG. But ...
Investment and leasing activity for life sciences assets nationwide is still finding its footing after a major market correction last year, and 2024 year-end data from JLL for the San Diego submarket ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Leasing activity in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results